The NIH and NIAID had patents for coronavirus spike protein for the vaccine in 2017

alpha

visibility 2936

World Affairs

7/19/2021, 2:04:56 AM


0 likes 0 comments


In light of developing demands for the state vaccine mandates, it is worth to re examine the National Institutes of Health and the NIAID work on development of stabilized coronavirus spike proteins for the development of vaccines against coronaviruses, now well known gain of function research conducted under the NIAID and NIH sponsorship and their ownership of underlying intellectual property for a leading coronavirus vaccine developed in conjunction with Moderna, according to documents obtained by Axios

Axios reported last spring, “NIH said in a statement that its scientists created the "stabilized coronavirus spike proteins for the development of vaccines against coronaviruses, including SARS-CoV-2," in 2016 and filed related patents in October 2016, 2017 and 3/8/2021... https://www.ott.nih.gov/bundle/tab-3261 the government consequently has "sought patents to preserve the government's rights to these inventions."

It is known that NIH and Moderna have researched coronaviruses for several years, and eventually signed a contract in December2019 a few months before Sarscov2 pandemic emerged publicly that stated "mRNA coronavirus vaccine candidates are developed and jointly owned" by the two parties. The contract was signed before the new virus had been sequenced.

NIH added that "federal employees listed as inventors on these patent appli assigned their rights to the U.S. government. Accordingly, the U.S. government holds ownership interest in the patents”

Since December 2019 moderna shares gained 15 times of its December value of 19$ per share to currently as of July 15 2021 286$/share.